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INTRODUCTION
Chronic cerebral hypoperfusion is associated with the develop­
ment of numerous neurological diseases (Dubois and Hebert, 
2001). A moderate but persistent reduction in cerebral blood flow 
affects neural structure mediating memory processes over a long 
period and eventually leads to the development and progression 
of vascular dementia (VaD) (Farkas et al., 2007), which is the second 
most common type of dementia following Alzheimer’s disease (AD). 
The neurobiological markers and signaling pathway underlying AD 
have been well established, whereas its role in VaD has not been well 
characterized. 
To understand the role of chronic cerebral hypoperfusion in the 
development of cognitive dysfunction in VaD, it is important to 
explore the causal relationships between cerebral hypoperfusion 
and dependant events such as changes in neurobiological markers, 
signal pathway, and cognitive function. Furthermore, recognition 
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In the current investigation, the status of the septo­hippocampal cholinergic pathway and hippocampal mitogen­activated protein 
kinase (MAPK) signaling was examined in male Wistar rats with chronic cerebral hypoperfusion, which showed cognitive 
deficits based on assessment on a version of the Morris water maze. Chronic cerebral hypoperfusion was induced by bilateral 
common artery occlusion and maintained for 12 weeks until behavioral testing. Chronic cerebral hypoperfusion was shown to 
induce memory impairments and microglial activation in regions of white matter, including the fimbria of hippocampus. Choline 
acetyltransferase expression of the basal forebrain and expression of hippocampal MAPKs was decreased in rats with BCCAo 
compared to control rats. The results of this study suggest that cognitive decline induced by chronic cerebral hypoperfusion could be 
related to dysfunction of the basal forebrain cholinergic system and reduction of hippocampal MAPK activities.
Key words: vascular dementia, neuroinflammation, memory, cholinergic, MAPK, hippocampus
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited.Septal-hippocampal System in Rats with Chronic Cerebral Hypoperfusion
93 www.enjournal.org http://dx.doi.org/10.5607/en.2011.20.2.92
of particular cellular mechanisms in the chain of events from 
chronic cerebral hypoperfusion to a cognitive decline may identify 
potential targets for effective therapies. To accomplish this, chronic 
cerebral hypoperfusion was induced in male Wistar rats with 
permanent occlusion of bilateral common carotid artery (BCCAo), 
which reduces the cerebral blood flow persistently as occurs in 
human aging, AD and also in VaD (Otori et al., 2003). Therefore, 
studies using animals with BCCAo have been conducted to reveal 
the long­term consequences of chronic cerebral hypoperfusion 
that leads to VaD.
One of the consistently reported characteristics in studies using 
animals with BCCAo is microglial activation at white matter sites 
(Farkas et al., 2004). The injury of white matter visualized with 
clinical imaging techniques has been reported to coincide with 
cognitive disorders in patients with VaD (Barber et al., 1999). 
Specifically, microglial activation labeled by OX­42 or OX­6 is 
much more evident in the white matter, than in the gray matter 
of rat brains with BCCAo (Wakita et al., 1994). Subsequently, 
the microglial activation may exacerbate white matter lesions, 
since the activated microglias produce reactive oxygen species 
(ROS) and proinflammatory cytokines. Thus, chronic cerebral 
hypoperfusion invariably induces white matter lesions and 
scattered foci of cortical microinfarcts either with or without 
hippocampal damage (Wakita et al., 1994; Ni et al., 1995). Rats 
with BCCAo exhibit memory deficits. For example, rats with 
BCCAo failed to find a hidden platform in the Morris water 
maze task (Ohta et al., 1997) and committed more errors in the 
eight­arm radial maze in comparison with control rats (Ni et al., 
1994). The working memory that was measured using an object 
recognition task was also impaired in rats with BCCAo (Sarti et al., 
2002). 
Degeneration of basal forebrain cholinergic neurons (BFCN) 
has been found to be associated with the cognitive decline that 
occurs in VaD and AD because the BFCN widely innervates 
the hippocampus and cortex (Bartus et al., 1982; Sharp et al., 
2009). It was also reported in an animal study using BCCAo that 
hippocampal cholinergic markers were altered in the hippocampus 
(Ni et al., 1995; Kumaran et al., 2008). The present experiment 
was conducted to examine the choline acetyltransferase (ChAT) 
expression and microglial inflammation of BFCN and microglial 
inflammation of the fimbria of hippocampus in rats with spatial 
memory impairments induced by BCCAo. In addition, mitogen­
activated protein kinase (MAPK: ERK, JNK, p38) and MAPK 
phosphorylation of the hippocampus was examined in rats 
with BCCAo based on previous findings that dysfunction of the 
cholinergic septo­hippocampal system is associated with altered 
MAPK signaling (Williams et al., 2006; Williams et al., 2007; 
Giovannini et al., 2008). 
MATERIALS AND METHODS
Subjects
Thirty­five male Wistar rats were used in these experiments 
(12 weeks; Charles River Co., Gapeung, South Korea). The 
rats resided in a vivarium at Konkuk University for 2 weeks at 
the beginning of the experiment at a controlled temperature 
(22±1
oC) and humidity (50±10%) on a 12 hour alternate light/
dark cycle (lights on at 0800 h). Food and water were provided ad 
libitum throughout the experiment. All animal procedures were 
conducted in accordance with the approved institutional animal 
care procedures and guidelines of the institutional animal care and 
use committee of Konkuk University.
Surgical procedure
Animals were anesthetized using 5% isoflurane and oxygen 
mixture and maintained with 3% isoflurane during the surgical 
procedure. A midline incision was made to expose the bilateral 
common carotid arteries, which were tightly double ligated with 
silk sutures. With the exception of bilateral common carotid artery 
occlusion, a sham­operation was conducted in which control 
animals were subjected to the same procedure as those conducted 
on the BCCAo operated animals. The rectal temperature was 
maintained at 37.0±0.5
oC with a heating pad during surgery.
Behavioral task
Of the twenty­five rats that were subjected to BCCAo, three died 
before behavioral testing. In addition, one rat that showed large 
weight loss that lost their weight 80% than before the surgery was 
excluded from further behavior task.
As a result, ten rats per group were used for behavioral testing 
and neurobiological assays. Twelve weeks after the BCCAo 
surgery, the rats were trained in a Morris water maze task. The 
maze consisted of a round tank, 1.83 m in diameter and 0.58 m 
deep, that was filled to a depth of 35.5 cm with tepid (26±1
oC) 
water made opaque by the additional of non­toxic water soluble 
white paint (tempera). A moveable hidden circular platform (12 
cm in diameter) was placed at a fixed location and submerged 
about 2 cm below the water surface. The maze was surrounded 
by white curtains on which black cloth visual stimuli of various 
shapes and sizes were placed. The rats were allowed to swim for 
a maximum 90 seconds in one trial. Every session contained 
five trials across two days and the total training was composed 
of four sessions. Each trial started from different positions in the 
water maze tank. A probe trial was conducted 30 min after the Bo-Ryoung Choi, et al.
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second session and the fourth session to assess the development 
of spatial bias in the maze; thus, the entire training procedure 
included two probe trials for each rat. During these probe trials, 
the rats swam with the platform retracted to the bottom of the 
pool for 30 s, at which time the platform was raised to its normal 
position for completion of the trial. One week after the Morris 
water maze task with the hidden platform, all rats were tested in a 
Morris water maze tasks, visual platform version. The location of 
the visible platform varied from trial to trial in a single session of 
six training trials. And six rats that did not find the visual platform 
were considered as rats with visual problems and were excluded 
from behavior task analysis. A camera located above the center of 
the maze relayed images to a videocassette recorder and an HVS 
Image Analysis Computer System (Hampton, United Kingdom). 
Brain preparation
Approximately 7 days after the behavioral experiments, six rats 
per group were used for the histology and four rats per group for 
western blot analysis. The rats used for the histology were deeply 
anesthetized with ketamin HCl (30 mg/kg) and xylazine (2.5 
mg/kg) cocktail, after which they were intracardially perfused 
with 0.01 M phosphate buffered saline (PBS) followed by 4% 
paraformaldehyde (PFA). The brain was then removed and 
postfixed in 4% PFA (2 d), cryoprotected in PBS containing 30% 
sucrose (48 h), frozen on powdered dry ice and stored at −70
oC 
until processed. And the other rats used for the western blot 
analysis were decapitated and the brain was rapidly removed at a 
4
oC surface. The hippocampi and BFCN were dissected, rapidly 
frozen on powered dry ice and stored at −80
oC until processed.
Thionin staining
Perfused brain tissues were sectioned on microtome in 40μm 
coronal plane and stored in 4
oC PBS. In each set of six serial 
sections, every first section was mounted on slides for thionin 
staining. The sections for thionin staining were mounted onto 
resin coated slide glass, and then dried up for 10 days. Sections 
were hydrated through descending concentration of ethanol 
and subsequently dipped in distilled water twice. Sections were 
stained in thionin solution for few minutes and washed in distilled 
water and ethanol, and then dehydrated through ascending 
concentration of ethanol. Then sections were defatted in Xylene 
and coverslipped with permount reagent.
OX-6 immunohistochemistry
Every second section in each set of six serial sections was used for 
immunohistochemistry (OX­6). The monoclonal antibody OX­6 
(mouse anti­RT1B monoclonal antibody, BD bioscience; 1 : 1,000) 
is directed against the major histocompatibility complex (MHC) 
class II antigen in the microglia. For OX­6 immunoreactivity, 
endogenous peroxidase of free floating sections was quenched 
by 30 min of incubation in 3% H2O2/10% MeOH in PBS. The 
sections were then incubated for one hour at room temperature 
in PBS with 0.3% Triton­X 100 containing 10% serum (PBS­T­S). 
Next, the sections were then incubated with OX­6 antibody for 
a further 12 h at 4
oC in 3% PBS­T­S solution. The sections were 
then incubated for 1h in horse anti­mouse antibody (vector; 1 : 
200) and then for 1h in ExtrAvidin peroxidase conjugate (Sigma 
Aldrich; 1 : 1,000). Finally, the sections were reacted with a Vector 
SG substrate kit (Sigma Aldrich) for peroxidase and mounted 
onto resin coated slides, after which they were dried for up to one 
week. Dried sections on slides were coverslipped with permount 
reagent. For quantifying the activated microglias, OX­6 antibody 
detected microglias were counted in corpus callosum and fimbria 
at six sites of brain section per an animal and statistically analysis. 
Western blot analysis
Proteins for the analysis of ChAT, MAPK, and pMAPK were 
extracted in the following manner. Individual tissue samples 
were weighed and then homogenized in 5 vol of ice­cold buffer 
containing 20 mM Tris at pH 7.5, 5% glycerol, 1.5 mM EDTA, 
40 mM KCl, 0.5 mM dithiothreitol, and protease inhibitors (No. 
539131, Calbiochem). Homogenates were centrifuged at 20,800 
g for 30 min at 4
oC. The supernatant was then removed from 
each sample, after which an aliquot was taken for determination 
of the total protein concentration using Bradford Reagent. The 
proteins were then separated by SDS­PAGE and transferred 
to a PVDF membrane, which was incubated with a primary 
antibody (Ab) against ChAT (1 : 1,000, Cell Signaling), ERK (1 
: 5,000, Cell Signaling), JNK (1 : 5,000, Cell Signaling), p38 (1 : 
1,000, Cell Signaling), pERK (1 : 3,000, Cell Signaling), pJNK (1 : 
3,000, Cell Signaling), and pp38 (1 : 1,000, Cell Signaling). After 
primary incubation, blots were incubated with the horseradish 
peroxidase (HRP)­conjugated secondary Ab (1 : 2,500, Amersham 
Biosciences) and then visualized using an ECL system and 
developed using Hyperfilm (Amersham).The relative expression 
levels of ChAT, MAPK, and pMAPK were determined by 
densitometry and normalization to β­actin (1 : 5,000, Sigma), an 
invariant cytoskeletal protein. 
Statistic analysis
A one­way repeated ANOVA and a t­test were conducted 
to assess the effects of chronic BCCAo on the spatial memory 
impairment, OX­6 expression, and MAPK changes. All data were 
expressed as the mean±SEM. Any p values that were less than 0.05 Septal-hippocampal System in Rats with Chronic Cerebral Hypoperfusion
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were considered significant, unless otherwise specified.
RESULTS
Spatial memory
In the spatial learning with Morris water maze task, search errors 
that are described in detail elsewhere (Gallagher et al., 1993) were 
used to assess the performance accuracy of spatial learning in the 
water maze. During each trial, the distance of the rats from the 
escape platform was sample 10 times per sec, and these values 
were averaged in 1­s bins. The cumulative search error was then 
calculated as the summed 1­sec averages of this proximity measure 
corrected for the particular start location on each trial. As shown 
in Fig. 1, the sham­operated control rats quickly became proficient 
at locating the submerged platform during the training sessions; 
however, the rats with BCCAo showed poor improvements over 
the course of training compared with the control rats (Fig. 1). 
One­way repeated ANOVA showed that the between group effects 
(sham­operated control, BCCAo) were significant (F(1,18)=28.13, 
p<0.001) and that the training effects (session) were significant 
(F(3,54)=19.75, p<0.001). There were also interaction effects between 
the group and training (F(3,54)=3.23, p=0.03). 
In addition, although no apparent differences in performance in 
the first probe trial were observed, there were apparent differences 
in performance in the second probe trial, as assessed by the 
percentage of time spent in the target quadrant during the 30 s 
probe. The t­test on the second probe trial showed that the group 
effects were significant (t(18)=4.01, p<0.01). On the first probe 
trial, the percentage of time spent in the target quadrant was less 
than 30% in rats of both groups, which indicated that they did not 
fully learn the hidden platform location after 10 trials. 
Swimming speeds during training trials and cue training: there 
were no significant differences in the swimming speeds between 
groups during training (F(1,18)=1.03, ns). The times taken to reach 
the visible platform (in seconds) during the block of cue­training 
trials (mean±S.E.M.) for the two groups were as follows: sham­
operated, 15.05±2.39; BCCAo, (22.44±1.67). There were no 
significant differences between the sham­operated group and the 
BCCAo group (F(1,10)=0.23, p=0.64).
ChAT reduction in BFCN and damaged in fimbria by 
BCCAo
The ChAT expression of BFCN was measured in rats with 
chronic cerebral hypoperfusion. The ChAT expression of BFCN 
of rats with BCCAo was decreased by more than 30% compared 
with the sham­operated group (t(6)=2.43, p<0.05) (Fig. 2A, 2B). 
However, upon staining for MHC class II antigen (OX­6), the 
OX­6 expression was not shown in the basal forebrain of rats 
with chronic cerebral hypoperfusion (Fig. 2C). Conversely, OX­6 
expression was increased in the fimbria of hippocampus (Fig. 
2D, 2E), which was statistically different from the sham­operated 
Fig. 1. Spatial memory impairments of rats with BCCAo. (A) Rats 
with BCCAo showed greater error when attempting to find the hidden 
platform compared with sham­operated rats. The value represents the 
mean search error of five­trial block±SEM (ten rats per group) (B). The 
percentage of time spent in the target quadrant during the 30 s probe. 
Sham­operated control rats showed the spatial bias on the second probe 
trial when compared with the BCCAo rats.
Fig. 2. Alternations of cholinergic septo­hippocampal system in rats with 
BCCAo. (A, B) ChAT expression in the basal forebrain was decreased 
by more than 30% in rats with BCCAo compared with sham­operated 
rats. (C) Interestingly, OX­6 immunostaining showed that no microglial 
activation in the basal forebrain occurred in both the sham­operated and 
the BCCAo group. (D, E) Microglial cells were more activated in fimbria 
of rats with BCCAo than in those of sham­operated rats.
A
A
C
D
B
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control (t(10)= 2.50, p<0.05).
Hippocampal neuron and microglial activation in white 
matter area 
Upon thionin staining of the hippocampus, no apparent neuronal 
cell death was observed in rats with BCCAo, but neuronal cell 
death occurred in the CA1 regions of the hippocampus in one animal 
(Fig. 3A). Consistent with earlier reports conducted using BCCAo, 
in the present experiment, expression of OX­6 was increased in 
the white matter regions such as the corpus callosum, external 
cap sule, and internal capsule (Fig. 3B). In particular, the number of 
activated microglia in the corpus callosum was statistically higher 
than those of sham­operated group (t(10)=2.55, p<0.05).
MAPK alterations in hippocampi of BCCAo
Increases of ERK and p38 abundances of the hippocampus in 
rats with BCCAo were statistically significant compared with those 
of the sham­operated control (t(6)> −3.96, p<0.01), while JNK 
did not show differences. Phosphorylation of the hippocampus 
MAPK was also analyzed in the BCCAo rats and the control 
rats. The extent of phosphorylation of hippocampus MAPK was 
evaluated with respect to MAPK abundances (pMAPK/MAPK). 
All phosphorylations of MAPKs (pERK, pJNK, and pp38) were 
significantly decreased in the hippocampus of rats with BCCAo in 
comparison with those of the sham­operated control (t(6)>2.51, 
p<0.05) (Fig. 4). 
DISCUSSION
In this experiment, chronic cerebral hypoperfusion was 
induced for 12 weeks by BCCAo of three month­old male Wistar 
rats. Previous studies reported that BCCAo led to reductions 
in cerebral blood flow (CBF) ranging from 30% to 40% of that 
before operation, and this remained at 52~64% between seven 
and thirty days after operation (Tomimoto et al., 2003). Between 
8 and 12 weeks after BCCAo, CBF was slightly reduced or not 
reduced (Ohta et al., 1997; Otori et al., 2003). The most common 
characteristic in rats with BCCAo is neuroinflammatory response 
in white matter and memory impairments (Farkas et al., 2007). 
The results of the present experiment showed that microglia was 
activated in the majority of the brain, especially in white matter 
regions such as the corpus callosum, internal capsule, and external 
capsule, and that memory impairment occurred in rats with 
BCCAo. The results of this experiment are consistent with those 
of earlier reports (Wakita et al., 2002; Takizawa et al., 2003; Farkas 
et al., 2004), which confirms that rats with BCCAo are a suitable 
Fig. 4. Altered MAPK expression in 
the hippocampi of rats with BCCAo. 
(A) Representative western blots of 
MAPKs. (B) All phosphorylations of 
MAPKs (pERK, pJNK, and pp38) were 
significantly decreased in rats with 
BCCAo in comparison with those of 
sham­operated control rats. (C) ERK 
and p38 abundances were significantly 
increased in hippocampi in rats 
with BCCAo, while JNK showed no 
difference.
Fig. 3. Photomicrographs of the thionin stained hippocampi and the 
OX­6 immunostained white matter regions in rats with BCCAo. (A) 
Based on thionin staining, hippocampal CA1 neuronal cell death was not 
apparent in rats with BCCAo except for one animal. (B) In the BCCAo 
group, activated microglia was highly expressed in white matter regions 
such as the corpus callosum, external capsule, and internal capsule 
compared with sham­operated control rats.
A
A B C
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animal model for chronic cerebral hypoperfusion although the 
CBF was not measured in this experiment.
Cognitive deficit in the BCCAo group was measured in the 
spatial learning version of the water maze task; however, rats with 
BCCAo showed comparable swimming speed to those of sham­
operated control rats and were also unimpaired in the cued version 
of the task. The results indicate that the deficits are not attributable 
to general motivation or to sensorimotor deficits (Gallagher et al., 
1993). 
It is stated that the level of cerebral hypoperfusion by BCCAo 
is moderate and that the resulting neuronal loss is very regional 
(e.g. hippocampal CA1) (Farkas et al., 2007). It is well known that 
neuronal loss in the hippocampal CA1 cell layer and memory 
impairments occurs in the brain of rats with BCCAo (Ni et al., 
1994; Bennett et al., 1998). However, it is not certain if neuronal 
loss occurs at long survival times after permanent BCCAo is 
induced by the initial phase of cerebral hypoperfusion, or if it is 
the outcome of a long­lasting neurodegeneration caused by the 
chronic phase of BCCAo or both. A series of studies have shown 
that the neuronal loss in the CA1 became greater as the survival 
times was increased (Ni et al., 1994), and that the neuronal loss in 
CA1 appeared at four months, but not one month after permanent 
BCCAo. Unlike neuronal loss, the lesion of white matter was 
observed one months after permanent BCCAo and increased 
markedly four months after the operation (Ni et al., 1995). In 
the current experiment, after three months of survival time only 
one animal showed clear neuronal loss in the hippocampal CA1. 
There was no clear neuronal loss in the hippocampus in any of the 
animals. Nevertheless, it is still a possibility that these cognitive 
deficits might be caused by some minor neuronal loss induced by 
BCCAo.
However, white matter injury was apparent in all rats with 
BCCAo. The fimbria of the hippocampus was damaged by 
activated microglia similar to other white matter regions such as 
the corpus callosum, external capsule, and internal capsule. The 
fimbria of hippocampus is part of the hippocampal circuitry and 
consists of a major axon bundle that originates from the basal 
forebrain to the hippocampus. Animals with fimbria­fornix injury 
failed to learn the spatial learning task in the Morris water maze, 
but this was recovered with septal cell grafts (Nilsson et al., 1987). 
Dysfunction of septo­hippocampal systems was implicated in rats 
with BCCAo that showed changes in the central acetylcholine 
and choline contents and decreases of hippocampal cholinergic 
muscarinic receptor and ChAT expression. The ChAT and 
OX­6 expression of the basal forebrain was examined in rats 
with BCCAo. The abundances of ChAT were decreased in the 
basal forebrain of rats with BCCAo compared to control rats, but 
activated microglias labeled with OX­6 were not observed. When 
combined with earlier reports, white matter damage in the fimbria 
of hippocampus might cause a reduction of ChAT in the basal 
forebrain and alterations of hippocampal signaling. 
Accordingly, we examined the status of MAPK signaling, which 
is a key regulator in neuroinflammation of AD (Haddad, 2004), 
although slight neuron loss was observed in the hippocampus in 
the BCCAo rats in the present experiment. In this experiment, 
ERK and p38 abundances of the hippocampus were increased 
and the MAPKs examined were less phosphorylated relative 
to the control rats. Interestingly, in our recent experiment, 
phosphorylations of hippocampal MAPKs were increased in 
rats with two months survival time after BCCAo (unreported 
observations). These results suggest that MAPKs reflect an 
ongoing process of inflammation in VaD and AD. 
The white matter damage caused by neuroinflammation is 
similar to the major pathological symptoms that occurs during 
VaD (Tomimoto et al., 1996). In addition, these white matter 
lesions in animal models with BCCAo share common features 
with VaD (Ueno et al., 2002; Tomimoto et al., 2003). The present 
study, which examined rats that survived for three months after 
BCCAo, is the first report that ChAT of the basal forebrain was 
decreased and that hippocamal MAPK signaling was altered. 
Interestingly, the findings that ChAT of the basal forebrain was 
decreased are strengthened by the clinical report that patients with 
VaD show cholinergic deficits in the brain and cerebrospinal fluid 
(CSF), and that it had significant benefits in cognition following 
treatment with donepezil, an acetylcholinesterase inhibitor 
(Roman et al., 2005; Wang et al., 2009). Moreover, the findings that 
the hippocampal signaling pathway related to MAPKs is altered in 
an animal model of VaD provide a new therapeutic target for the 
development of antidementia agents.
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